Goyot C, Debray Q, Hug R, Grenier J
Encephale. 1985 Mar-Apr;11(2):45-51.
Prolactin, growth hormone and thyrotropin plasma levels have been evaluated in depressive in-patients, either during the first day of clomipramine or amitriptyline treatment, or after their chronic administration. Prolactin levels temporary rise during the first day of clomipramine or amitriptyline treatment in 6 patients out of 11, with a lag in relation to the drug plasma peak. A significant increase is observed after a 28 days treatment with clomipramine and a non significant decrease, after a 28 days treatment with amitriptyline. As for human growth hormone, a rise is found in 5 out of 8 clomipramine treated subjects but neither any variation with amitriptyline nor any significant variation with chronic administration of both drugs occur. Finally, thyrotropin plasma levels display no variation after acute or prolonged treatment with clomipramine or amitriptyline. These results are compared with those of literature, then discussed in the light of present theories on pituitary hormones secretion aminergic control and of tricyclic antidepressants effect on these hormones.
我们评估了抑郁症住院患者在接受氯米帕明或阿米替林治疗的第一天以及长期用药后催乳素、生长激素和促甲状腺激素的血浆水平。11名患者中有6名在氯米帕明或阿米替林治疗的第一天催乳素水平暂时升高,且与药物血浆峰值存在时间滞后。氯米帕明治疗28天后观察到显著升高,而阿米替林治疗28天后则出现不显著的下降。至于人生长激素,8名接受氯米帕明治疗的受试者中有5名出现升高,但阿米替林治疗未出现任何变化,两种药物长期使用也未出现任何显著变化。最后,氯米帕明或阿米替林急性或长期治疗后促甲状腺激素血浆水平均无变化。我们将这些结果与文献结果进行了比较,然后根据目前关于垂体激素分泌胺能控制的理论以及三环类抗抑郁药对这些激素的影响进行了讨论。